These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18220817)

  • 1. TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications.
    Starowicz K; Cristino L; Di Marzo V
    Curr Pharm Des; 2008; 14(1):42-54. PubMed ID: 18220817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Hotheaded": the role OF TRPV1 in brain functions.
    Martins D; Tavares I; Morgado C
    Neuropharmacology; 2014 Oct; 85():151-7. PubMed ID: 24887171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hot receptors in the brain.
    Steenland HW; Ko SW; Wu LJ; Zhuo M
    Mol Pain; 2006 Nov; 2():34. PubMed ID: 17092351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A patent review of transient receptor potential vanilloid type 1 modulators (2014-present).
    Gao M; Wang Y; Liu L; Qiao Z; Yan L
    Expert Opin Ther Pat; 2021 Feb; 31(2):169-187. PubMed ID: 33377418
    [No Abstract]   [Full Text] [Related]  

  • 5. Supraspinal Transient Receptor Potential Subfamily V Member 1 (TRPV1) in Pain and Psychiatric Disorders.
    Madasu MK; Roche M; Finn DP
    Mod Trends Pharmacopsychiatry; 2015; 30():80-93. PubMed ID: 26436415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1.
    Gavva NR
    Trends Pharmacol Sci; 2008 Nov; 29(11):550-7. PubMed ID: 18805596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain TRPV1: a depressing TR(i)P down memory lane?
    Di Marzo V; Gobbi G; Szallasi A
    Trends Pharmacol Sci; 2008 Dec; 29(12):594-600. PubMed ID: 18947889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
    Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
    Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting TRPV1 for pain relief: limits, losers and laurels.
    Szallasi A; Sheta M
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1351-69. PubMed ID: 22780443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.
    Maiese K
    Curr Neurovasc Res; 2017; 14(2):184-189. PubMed ID: 28294062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymodal Transient Receptor Potential Vanilloid Type 1 Nocisensor: Structure, Modulators, and Therapeutic Applications.
    Cui M; Gosu V; Basith S; Hong S; Choi S
    Adv Protein Chem Struct Biol; 2016; 104():81-125. PubMed ID: 27038373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of modality-specific transient receptor potential vanilloid-1 antagonists that do not alter body temperature.
    Reilly RM; McDonald HA; Puttfarcken PS; Joshi SK; Lewis L; Pai M; Franklin PH; Segreti JA; Neelands TR; Han P; Chen J; Mantyh PW; Ghilardi JR; Turner TM; Voight EA; Daanen JF; Schmidt RG; Gomtsyan A; Kort ME; Faltynek CR; Kym PR
    J Pharmacol Exp Ther; 2012 Aug; 342(2):416-28. PubMed ID: 22570364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms.
    Gunthorpe MJ; Szallasi A
    Curr Pharm Des; 2008; 14(1):32-41. PubMed ID: 18220816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anandamide and the vanilloid receptor (TRPV1).
    Tóth A; Blumberg PM; Boczán J
    Vitam Horm; 2009; 81():389-419. PubMed ID: 19647120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptome: Interactions between three pain-related receptors or the "Triumvirate" of cannabinoid, opioid and TRPV1 receptors.
    Zádor F; Wollemann M
    Pharmacol Res; 2015 Dec; 102():254-63. PubMed ID: 26520391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient receptor potential vanilloid type 1 and pain development.
    Palazzo E; Luongo L; de Novellis V; Rossi F; Marabese I; Maione S
    Curr Opin Pharmacol; 2012 Feb; 12(1):9-17. PubMed ID: 22104468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the TRPV1 channel in the modulation of spontaneous locomotor activity, physical performance and physical exercise-induced physiological responses.
    Hudson AS; Kunstetter AC; Damasceno WC; Wanner SP
    Braz J Med Biol Res; 2016; 49(6):e5183. PubMed ID: 27191606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?
    Moreira FA; Aguiar DC; Terzian AL; Guimarães FS; Wotjak CT
    Neuroscience; 2012 Mar; 204():186-92. PubMed ID: 21906661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of TRPV1 receptors in descending modulation of pain.
    Palazzo E; Rossi F; Maione S
    Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S79-83. PubMed ID: 18325659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hot flash: TRPV channels in the brain.
    Kauer JA; Gibson HE
    Trends Neurosci; 2009 Apr; 32(4):215-24. PubMed ID: 19285736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.